The impact of glucose control on macrovascular complications is less certain but is supported by multiple meta-analyses and epidemiological studies
The FDA advises consumers to obtain semaglutide-based drugs only if they have a prescription from a licensed medical provider and to only get the drugs from state-licensed pharmacies or FDA-registered outsourcing facilities
Obese children and adolescents are at a greater risk of numerous health conditions, some of which include dysglycemia, high blood pressure, nonalcoholic fatty liver disease, obstructive sleep apnea, dyslipidemia, altered mental health, and reduced quality of life
Two important cautions deserve emphasis: GLP-1 medications are not recommended during pregnancy, and planned discontinuation prior to conception is advised
The price of weight loss medications in Australia can differ significantly based on the specific drug and its purpose